Ocugen, Inc.

Ocugen, Inc.

0.77
USD
-0.05
(-6.62%)
-0.20EPS
349.49MMarket Cap
Mar 10Next Earn

Total Valuation

USD

As of September 30, 2026, Ocugen, Inc. carries a market capitalization of 349.49M, placing it among publicly traded companies globally. Its enterprise value stands at 353.79M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap349.49M
Enterprise Value353.79M

Important Dates

Ocugen, Inc.'s next confirmed earnings release is scheduled for March 10, 2027.

Earnings Date3/10/2027

Share Statistics

As of September 30, 2026, Ocugen, Inc. has 339.31M shares outstanding.

Shares Outstanding339.31M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 71.00, and the price-to-book ratio stands at -19.77.

PS Ratio71.00
PB Ratio-19.77
P/TBV Ratio-19.77
P/FCF Ratio-5.31
P/OCF Ratio-5.33

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 74.03 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 353.79M versus a market cap of 349.49M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales74.03

Financial Position

As of September 30, 2026, Ocugen, Inc. maintains a current ratio of 0.77, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -500.89, indicating conservative leverage, while an interest coverage ratio of -6.63 demonstrates limited ability to service its debt obligations.

Current Ratio0.77
Quick Ratio0.71
Debt / Equity-500.89
Debt / EBITDA-1.31
Interest Coverage-6.63

Financial Efficiency

USD

These figures cover the twelve months ended September 30, 2026. Return on assets (ROA) is negative at -78.91, reflecting losses generated across the asset base. The company generates approximately 41,198.28 in revenue per employee across its workforce of 116.00, a quick read on workforce productivity versus industry peers.

Return on Assets (ROA)-78.91
Revenue Per Employee41,198.28
Employee Count116.00

Stock Price Statistics

USD

As of the close on November 16, 2026, Ocugen, Inc.'s stock has declined approximately 35.04% over the past 52 weeks. The 50-day moving average sits at 0.92, while the 200-day moving average is 1.39.

52-Week Price Change-35.04%
50-Day Moving Average0.92
200-Day Moving Average1.39

Income Statement

USD

Over the twelve months ended September 30, 2026, Ocugen, Inc. generated 4.78M in revenue and converted that into -65.36M in net income, yielding earnings per share of -0.20. EBITDA reached -67.70M, while operating income came in at -69.03M.

Revenue4.78M
Operating Income-69.03M
Pretax Income-65.36M
Net Income-65.36M
EBITDA-67.70M
EBIT-69.03M
Earnings Per Share (EPS)-0.20

Balance Sheet

USD

As of September 30, 2026, Ocugen, Inc. holds 84.26M in cash and equivalents against 88.56M in total debt, resulting in a net debt position of 60.26M. Total book value stands at -17.68M, with working capital of -27.47M providing operational flexibility.

Cash & Cash Equivalents84.26M
Total Debt88.56M
Net Debt60.26M
Equity (Book Value)-17.68M
Book Value Per Share-0.05
Working Capital-27.47M

Cash Flow

USD

Ocugen, Inc. produced -63.69M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -211,000.00 in capital expenditures, free cash flow totaled -63.90M - equivalent to -0.19 per share.

Operating Cash Flow-63.69M
Capital Expenditures-211,000.00
Free Cash Flow-63.90M
FCF Per Share-0.19

Margins

These figures cover the twelve months ended September 30, 2026. The operating margin of -1,444.47 and net profit margin of -1,367.61 provide insight into operational efficiency.

Operating Margin-1,444.47
Pretax Margin-1,367.61
Profit Margin-1,367.61
EBITDA Margin-1,416.70

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield is negative at -18.83: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -33.05, meaning Ocugen, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-33.05
FCF Yield-18.83

Stock Splits

Ocugen, Inc.'s most recent stock split took place on September 30, 2019 with a 60:1 split ratio.

Last Split Date9/30/2019
Split Ratio60:1

Scores

As of September 30, 2026, Ocugen, Inc. has an Altman Z-Score of -6.61, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-6.61